Activation of catalase by apelin prevents oxidative stress-linked cardiac hypertrophy

FEBS Letters

Volumn 584, Issue 11, 2010, Pages 2363-2370

  Foussal, Camille ^a,b   Lairez, Olivier ^a   Calise, Denis ^d   Pathak, Atul ^a,b   Guilbeau Frugier, Celine ^c   Valet, Philippe ^a,b   Parini, Angelo ^a,b   Kunduzova, Oksana ^a,b  

^a INSERM   (France)

^b UNIVERSITÉ DE TOULOUSE   (France)

^c CHU   (France)

^d IFR150 Rangueil   (France)

Author keywords

Apelin; Cardiomyocyte; Catalase; Hypertrophy; Oxidative stress; Pressure overload

Indexed keywords

ACTIN; ALPHA SKELETAL MUSCLE ACTIN; APELIN; ATRIAL NATRIURETIC FACTOR; BRAIN NATRIURETIC PEPTIDE; CATALASE; GLUTATHIONE PEROXIDASE; HYDROGEN PEROXIDE; LIPID HYDROPEROXIDE; MYOSIN HEAVY CHAIN BETA; PARGYLINE; REACTIVE OXYGEN METABOLITE; SEROTONIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIOXIDANT ACTIVITY; ARTICLE; CHRONIC DRUG ADMINISTRATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; GENE EXPRESSION; HEART FAILURE; HEART LEFT VENTRICLE OVERLOAD; HEART MUSCLE CELL; HEART VENTRICLE HYPERTROPHY; MALE; MOUSE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; UPREGULATION;

ANIMALS; CARDIOMEGALY; CATALASE; HYDROGEN PEROXIDE; HYPERTROPHY; HYPERTROPHY, LEFT VENTRICULAR; MICE; MYOCARDIUM; MYOCYTES, CARDIAC; OXIDATIVE STRESS; RATS; REACTIVE OXYGEN SPECIES; SEROTONIN;

MUS;

EID: 77952954603     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.febslet.2010.04.025     Document Type: Article

References (39)

1. Bupha-Intr T., Holmes J.W., Janssen P.M. Induction of hypertrophy in vitro by mechanical loading in adult rabbit myocardium. Am. J. Physiol. Heart Circ. Physiol. 2007, 293:H3759-H3767.
2. Vandenburgh H.H., Solerssi R., Shansky J., Adams J.W., Henderson S.A. Mechanical stimulation of organogenic cardiomyocyte growth in vitro. Am. J. Physiol. 1996, 270(5 Pt 1):C1284-C1292.
3. Yamazaki T., Komuro I., Yazaki Y. Molecular mechanism of cardiac cellular hypertrophy by mechanical stress. J. Mol. Cell. Cardiol. 1995, 27:133-140.
4. Dzau V.J. The role of mechanical and humoral factors in growth regulation of vascular smooth muscle and cardiac myocytes. Curr. Opin. Nephrol. Hypertens. 1993, 2:27-32.
5. Schultz Jel J.J., Witt S.A., Glascock B.J., Nieman M.L., Reiser P.J., Nix S.L., Kimball T.R., Doetschman T. TGF-beta1 mediates the hypertrophic cardiomyocyte growth induced by angiotensin II. J. Clin. Invest. 2002, 109:787-796.
6. Tamamori M., Ito H., Adachi S., Akimoto H., Marumo F., Hiroe M. Endothelin-3 induces hypertrophy of cardiomyocytes by the endogenous endothelin-1-mediated mechanism. J. Clin. Invest. 1996, 97:366-372.
7. Stuck B.J., Lenski M., Böhm M., Laufs U. Metabolic switch and hypertrophy of cardiomyocytes following treatment with angiotensin II are prevented by AMP-activated protein kinase. J. Biol. Chem. 2008, 283:32562-32569.
8. Domenighetti A.A., Wang Q., Egger M., Richards S.M., Pedrazzini T., Delbridge L.M. Angiotensin II-mediated phenotypic cardiomyocyte remodeling leads to age-dependent cardiac dysfunction and failure. Hypertension 2005, 46:426-432.
9. Karmazyn M., Purdham D.M., Rajapurohitam V., Zeidan A. Leptin as a cardiac hypertrophic factor: a potential target for therapeutics. Trends Cardiovasc. Med. 2007, 17:206-211.
10. Xu F.P., Chen M.S., Wang Y.Z., Yi Q., Lin S.B., Chen A.F., Luo J.D. Leptin induces hypertrophy via endothelin-1-reactive oxygen species pathway in cultured neonatal rat cardiomyocytes. Circulation 2004, 110:1269-1275.
11. Boucher J., Masri B., Daviaud D., Gesta S., Guigné C., Mazzucotelli A., Castan-Laurell I., Tack I., Knibiehler B., Carpéné C., Audigier Y., Saulnier-Blache J.S., Valet P. Apelin, a newly identified adipokine up-regulated by insulin and obesity. Endocrinology 2005, 146:1764-1771.
12. Jászberényi M., Bujdosó E., Telegdy G. Behavioral, neuroendocrine and thermoregulatory actions of apelin-13. Neuroscience 2004, 129:811-816.
13. Chandrasekaran B., Dar O., McDonagh T. The role of apelin in cardiovascular function and heart failure. Eur. J. Heart Fail. 2008, 10:725-732.
14. Horiuchi Y., Fujii T., Kamimura Y., Kawashima K. The endogenous, immunologically active peptide apelin inhibits lymphocytic cholinergic activity during immunological responses. J. Neuroimmunol. 2003, 144:46-52.
15. Japp A.G., Newby D.E. The apelin-APJ system in heart failure: pathophysiologic relevance and therapeutic potential. Biochem. Pharmacol. 2008, 75:1882-1892.
16. Dray C., Knauf C., Daviaud D., Waget A., Boucher J., Buléon M., Cani P.D., Attané C., Guigné C., Carpéné C., Burcelin R., Castan-Laurell I., Valet P. Apelin stimulates glucose utilization in normal and obese insulin-resistant mice. Cell Metab. 2008, 8:437-445.
17. Tatemoto K., Takayama K., Zou M.X., Kumaki I., Zhang W., Kumano K., Fujimiya M. The novel peptide apelin lowers blood pressure via a nitric oxide-dependent mechanism. Regul. Pept. 2001, 99:87-92.
18. Farkasfalvi K., Stagg M.A., Coppen S.R., Siedlecka U., Lee J., Soppa G.K., Marczin N., Szokodi I., Yacoub M.H., Terracciano C.M. Direct effects of apelin on cardiomyocyte contractility and electrophysiology. Biochem. Biophys. Res. Commun. 2007, 357:889-895.
19. Dai T., Ramirez-Correa G., Gao W.D. Apelin increases contractility in failing cardiac muscle. Eur. J. Pharmacol. 2006, 553:222-228.
20. Simpkin J.C., Yellon D.M., Davidson S.M., Lim S.Y., Wynne A.M., Smith C.C. Apelin-13 and apelin-36 exhibit direct cardioprotective activity against ischemia-reperfusion injury. Basic Res. Cardiol. 2007, 102:518-528.
21. Kleinz M.J., Baxter G.F. Apelin reduces myocardial reperfusion injury independently of PI3K/Akt and P70S6 kinase. Regul. Pept. 2008, 146:271-277.
22. Kuba K., Zhang L., Imai Y., Arab S., Chen M., Maekawa Y., Leschnik M., Leibbrandt A., Markovic M., Schwaighofer J., Beetz N., Musialek R., Neely G.G., Komnenovic V., Kolm U., Metzler B., Ricci R., Hara H., Meixner A., Nghiem M., Chen X., Dawood F., Wong K.M., Sarao R., Cukerman E., Kimura A., Hein L., Thalhammer J., Liu P.P., Penninger J.M. Impaired heart contractility in apelin gene-deficient mice associated with aging and pressure overload. Circ. Res. 2007, 101:e32-e42.
23. Iwanaga Y., Kihara Y., Takenaka H., Kita T. Down-regulation of cardiac apelin system in hypertrophied and failing hearts: possible role of angiotensin II-angiotensin type 1 receptor system. J. Mol. Cell Cardiol. 2006, 41:798-806.
24. Aikawa R., Nagai T., Tanaka M., Zou Y., Ishihara T., Takano H., Hasegawa H., Akazawa H., Mizukami M., Nagai R., Komuro I. Reactive oxygen species in mechanical stress-induced cardiac hypertrophy. Biochem. Biophys. Res. Commun. 2001, 289:901-907.
25. Cheng T.H., Shih N.L., Chen C.H., Lin H., Liu J.C., Chao H.H., Liou J.Y., Chen Y.L., Tsai H.W., Chen Y.S., Cheng C.F., Chen J.J. Role of mitogen-activated protein kinase pathway in reactive oxygen species-mediated endothelin-1-induced beta-myosin heavy chain gene expression and cardiomyocyte hypertrophy. J. Biomed. Sci. 2005, 12:123-133.
26. Wu S., Gao J., Ohlemeyer C., Roos D., Niessen H., Köttgen E., Gessner R. Activation of AP-1 through reactive oxygen species by angiotensin II in rat cardiomyocytes. Free Radic. Biol. Med. 2005, 39:1601-1610.
27. Higuchi Y., Otsu K., Nishida K., Hirotani S., Nakayama H., Yamaguchi O., Matsumura Y., Ueno H., Tada M., Hori M. Involvement of reactive oxygen species-mediated NF-kappa B activation in TNF-alpha-induced cardiomyocyte hypertrophy. J. Mol. Cell. Cardiol. 2002, 34:233-240.
28. Xu F.P., Chen M.S., Wang Y.Z., Yi Q., Lin S.B., Chen A.F., Luo J.D. Leptin induces hypertrophy via endothelin-1-reactive oxygen species pathway in cultured neonatal rat cardiomyocytes. Circulation 2004, 110:1269-1275.
29. Bianchi P., Pimentel D.R., Murphy M.P., Colucci W.S., Parini A. A new hypertrophic mechanism of serotonin in cardiac myocytes: receptor-independent ROS generation. FASEB J. 2005, 19:641-643.
30. Nakagami H., Takemoto M., Liao J.K. NADPH oxidase-derived superoxide anion mediates angiotensin II-induced cardiac hypertrophy. J. Mol. Cell. Cardiol. 2003, 35:851-859.
31. Day B.J. Catalase and glutathione peroxidase mimics. Biochem. Pharmacol. 2009, 77:285-296.
32. Maguire J., Kleinz J., Pitkin L., Davenport P. [Pyr1]apelin-13 identified as the predominant apelin isoform in the human heart: vasoactive mechanisms and inotropic action in disease. Hypertension 2009, 54:598-604.
33. Lairez O., Calise D., Bianchi P., Ordener C., Spreux-Varoquaux O., Guilbeau-Frugier C., Escourrou G., Seif I., Roncalli J., Pizzinat N., Galinier M., Parini A., Mialet-Perez J. Genetic deletion of MAO-A promotes serotonin-dependent ventricular hypertrophy by pressure overload. J. Mol. Cell. Cardiol. 2009, 46:87-95.
34. Pchejetski D., Kunduzova O., Calise D., Seif I., Leducq N., Parini A., Cuvillier O. Oxidative stress-dependent sphingosine kinase-1 inhibition mediates MAO-A-associated cardiac cell apoptosis. Circ. Res. 2007, 100:41-49.
35. Dhalla A.K., Hil M.F., Singal P.K. Role of oxidative stress in transition of hypertrophy to heart failure. J. Am. Coll. Cardiol. 1996, 28:506-514.
36. Zeng X.J., Zhang L.K., Wang H.X., Lu L.Q., Ma L.Q., Tang C.S. Apelin protects heart against ischemia/reperfusion injury in rat. Peptides 2009, 30:1144-1152.
37. Tsutsui H., Kinugawa S., Matsushima S. Mitochondrial oxidative stress and dysfunction in myocardial remodelling. Cardiovasc. Res. 2009, 81:449-456.
38. Colucci W.S. Molecular and cellular mechanisms of myocardial failure. Am. J. Cardiol. 1997, 80:15L-25L.
39. Murtaza I., Wang H.X., Feng X., Alenina N., Bader M., Prabhakar B.S., Li P.F. Down-regulation of catalase and oxidative modification of protein kinase CK2 lead to the failure of apoptosis repressor with caspase recruitment domain to inhibit cardiomyocyte hypertrophy. J. Biol. Chem. 2008, 283:5996-6004.